Evidence map›Paper›PMID 37901300›Full record

ReviewTransplant international : official journal of the European Society for Organ Transplantation2023

The Role of the Duffy Blood Group Antigens in Renal Transplantation and Rejection. A Mini Review.

Dana Hariri, Jozsef Bordas, Matthew Elkins, Brian Gallay, Zhanna Spektor, Reut Hod-Dvorai

Open access · goldAbstract readReview
In one paragraph

Review in Transplant international : official journal of the European Society for Organ Transplantation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. DARC and Anti-Duffy Antibodies in the Line of Fire: The Challenges in Pinpointing the Etiology of Microcirculation Inflammation to a Distinct Entity.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Dana HaririDepartment of Pathology, SUNY Upstate Medical University, Syracuse, NY, United States.
Jozsef BordasDepartment of Pathology, SUNY Upstate Medical University, Syracuse, NY, United States.
Matthew ElkinsDepartment of Pathology, SUNY Upstate Medical University, Syracuse, NY, United States.
Brian GallayDepartment of Medicine, SUNY Upstate Medical University, Syracuse, NY, United States.
Zhanna SpektorDepartment of Pathology, SUNY Upstate Medical University, Syracuse, NY, United States.
Reut Hod-DvoraiDepartment of Pathology, SUNY Upstate Medical University, Syracuse, NY, United States.
SUNY Upstate Medical University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Finding a compatible donor for kidney transplant candidates requires overcoming immunological barriers such as human leukocyte antigens (HLA) compatibility and ABO compatibility. Emerging data suggest a role for red blood cell antigens (RCA) in renal transplant outcomes. The incidence of RCA alloimmunization is high in chronically transfused individuals, such as end stage renal disease patients, but whether antibodies to RCA can mediate renal graft rejection remains debatable. The Duffy blood group antigens (Fy) has been shown to be expressed in the kidney, among other tissues. There are some data to suggest that donor-recipient Fy mismatches may increase the risk for chronic allograft damage and that anti-Fy antibodies may be involved in renal graft rejection, however, while it is routine to screen renal transplant candidates for ABO antigens, detailed RCA phenotyping of the donor kidney is not routinely tested. In this paper, we review the current data on the role of Fy in renal transplantation and discuss the potential mechanisms of its biological function.

Indexed as

Blood Group AntigensKidney DiseasesKidney TransplantationGraft RejectionGraft SurvivalHLA AntigensHumansPostoperative ComplicationsTissue DonorsTransplantation, HomologousBlood Group AntigensHLA AntigensalloantibodyDuffyred blood cells (RBC)rejectionrenal transplant

Identifiers

PMID37901300
PMCPMC10603226
OpenAlexW4387607259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.